
Laviceftra S 1000mg/500mg Injection
Marketer
Lavish Biotech
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Laviceftra S 1000mg/500mg Injection
Ceftolozane/tazobactam 1000mg/500mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be solely under a doctor's guidance. Complete the prescribed treatment regimen; premature cessation can compromise its effectiveness. Report any missed appointments promptly. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) require urgent medical care. Inform your physician about all current medications before starting this treatment, especially if you're pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, proper nutrition, and sufficient hydration are crucial for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment efficacy.
Uses of Laviceftra S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Laviceftra S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not recommended.
Common Side effects of Laviceftra S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Laviceftra S 1000mg/500mg Injection:
Administering this medication will be done by your physician or registered nurse; self-medication is strictly prohibited.
How Laviceftra S 1000mg/500mg Injection works:
Ceftriaxone/Sulbactam 1000mg/500mg Injection (Laviceftra S) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their survival. Sulbactam counteracts bacterial resistance mechanisms, thereby optimizing ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Laviceftra S 1000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Laviceftra S (1000mg/500mg) is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Laviceftra S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
The administration of Laviceftra S 1000mg/500mg Injection can lead to reduced alertness, impaired vision, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Laviceftra S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
The 1000mg/500mg Laviceftra S Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for the 1000mg/500mg Laviceftra S Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Laviceftra S 1000mg/500mg Injection :
Omitting a scheduled dose of Laviceftra S 1000mg/500mg Injection necessitates contacting your physician.
Facts to Know About Laviceftra S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
